Annette Doherty

Doherty trained in chemistry at Imperial College London. She was at Imperial for undergraduate and graduate studies, before moving to Ohio State University as a NATO research fellow. Her doctoral research investigated ionophore antibiotics. She joined the Royal Society of Chemistry as a student, and has said that she understood the value it can add to people at all stages of their chemistry careers. == Career ==

Doherty spent thirty-five years in the pharmaceutical industry. She was interested in the development of new diseases for respiratory, infectious and inflammatory conditions, as well as many cancers. She worked at Warner–Lambert and GSK. At GSK, she was Head of Product Development and Clinical Supply. In 2012, she moved to Pfizer, where she held similar leadership positions in drug development. Doherty is a Senior Advisor at Frazier Life Sciences, who design and develop new therapeutics. She was made an Honorary Fellow of the British Pharmacological Society in 2023. In May 2024 she was made Chair of Maidstone and Tunbridge Wells NHS Trust, where she spent one year before moving to East Kent Hospitals University NHS Foundation Trust. Doherty was elected President of the Royal Society of Chemistry in 2024. and serves on the council of Innovate UK. == Selected publications ==